drugset / Trial / NCT00960830

Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety

NCT00960830

Completed 40 enrolled Universidad Nacional de Rosario
RandomizedFactorialDouble-blindPrevention

Summary

The purpose of this study is to evaluate if the use of antidepressant medication in depressed patients with implantable cardioverter defibrillator reduces the number of ICD's shocks as it improves depressive affect.

Timeline

Start
2007-04
Primary completion
2008-04
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mirtazapine Other / unclassified 15 mg